Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases
- Resource Type
- Article
- Source
- In
Clinical Lymphoma Myeloma and Leukemia August 2015 15(8):458-463 - Subject
- Language
- ISSN
- 2152-2650